Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Where is HeartFlow actually being used routinely?
Still openWhether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Public evidence
WVU Heart and Vascular Institute at Wheeling Hospital introduces advanced HeartFlow technology to enhance cardiac care
SignalHunt:deployment:HeartFlow
Public evidence
St. Mary's Medical Center now using HeartFlow analysis, a novel AI diagnostic tool for heart disease
SignalHunt:deployment:HeartFlow
Public evidence
Heartflow Announces Favorable Coverage Determination for Plaque Analysis by Five Medicare Administrative Contractors
SignalHunt:deployment:HeartFlow
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
Nobody has answered these yet. Your experience can help us understand what is happening.
Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
Settled elsewhere. Context for reading the above, not something practice can confirm.
Tool intelligence
HealthAratus currently understands HeartFlow through deployment evidence, company records and external market activity.
HealthAratus is beginning to understand HeartFlow. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
The material the questions above were built from, with its attribution.
HeartFlow is an AI-powered platform that converts CCTA scans into 3D models of the coronary arteries. It provides clinicians with physiological and anatomical analysis to assist in managing coronary artery disease.According to HeartFlow
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
I have used HeartFlow to perform non-invasive physiological assessments of coronary lesions.
According to HeartFlow
Does this change your workflow?
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
WVU Heart and Vascular Institute at Wheeling Hospital introduces advanced HeartFlow technology to enhance cardiac care
Reported publicly
How widely is this actually used?
Reported deployment
St. Mary's Medical Center now using HeartFlow analysis, a novel AI diagnostic tool for heart disease
Reported publicly
How widely is this actually used?
Reported deployment
Heartflow Announces Favorable Coverage Determination for Plaque Analysis by Five Medicare Administrative Contractors
Reported publicly
How widely is this actually used?
Reported outcome
Heartflow’s Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
Reported publicly
Are you seeing this result?
Recent change
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
Reported publicly
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Vendor & external product information, not independently verified by HealthAratus
Deployed in mixed settings
How the reality here has changed
Earlier activity concentrated on adoption state, workflow friction, accuracy quality. More recent activity concentrates on adoption state, accuracy quality, workflow friction.
Earlier
More recently
Connected intelligence
Category intelligence